What If Detecting DiseaseS Was As Simple As Looking At Your Phone?BioTrillion is revolutionizing health monitoring by transforming smartphones into powerful medical devices. Our mission is to empower over 5 billion people with access to extraordinary health insights—using just their smartphone.• Introducing HealthySelfie™: Your Health in a 10-Second ScanOur groundbreaking HealthySelfie™ app leverages advanced computer vision and machine learning algorithms to quantify vital health information from a simple 10-second face scan. By democratizing access to medical-grade diagnostics, we enable anyone, anywhere, to proactively monitor their health.• Quantifying Ancient Wisdom with Modern TechnologyFor centuries, clinicians have recognized that the face reveals critical health insights. We've transformed this qualitative wisdom into precise, quantitative data using AI. Through innovative software, we amplify smartphone cameras already in billions of hands, achieving medical-grade assessments without the need for specialized hardware.• Multiple Massive Markets, One Simple SolutionBy utilizing existing smartphones, we eliminate barriers to entry and accelerate global adoption. Our software-based platform allows rapid scaling without hardware limitations, making it ideal for:-Telehealth-Decentralized Clinical Trials-Insurance Risk Management-Consumer Health EmpowermentThe Future of Healthcare in Your Hands!

Healthcare Investment Banking.Recruited to assist with expansion of Healthcare Investment Banking. Developed relationships and executed deals with biotech, medtech, and diagnostic clients. Promoted early to Managing Director.

Healthcare Investment Banking.Executed ~40 Life Sciences M&A, IPO, corporate strategy deals worth $35B across spectrum of drug, diagnostic, and device technologies. Led Deutsche Bank’s expansion of Healthcare business in Asia, spending 1 year in China, living in Hong Kong. Promoted from Associate to Vice President to Director (early).

Healthcare Investment Banking.Focused global large and mid-cap life sciences corporations. Led deal teams and executed M&A, equity and debt financings, often involving deep scientific due diligence. Promoted from Analyst to Associate.

Little bioengineer in a big lab, focused on oligonucleotide sequencing.